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Background: The calcium-activated chloride channel ANO1 regulates multiple physiological processes.
Results:We identified residues that whenmutated affected channel activity, intracellular trafficking, or localization and report
the first structure-function map of ANO1.
Conclusion: The re-entrant loop mediates calcium/voltage sensitivity and activation of ANO1.
Significance:We provide new tools for studying ANO1 function in biological systems and its potential as a therapeutic target.
The calcium-activated chloride channelANO1regulatesmul-
tiple physiological processes. However, little is known about the
mechanism of channel gating and regulation of ANO1 activity.
Using a high-throughput, randommutagenesis-based variomics
screen, we generated and functionally characterized 6000
ANO1 mutants and identified novel mutations that affected
channel activity, intracellular trafficking, or localization of
ANO1. Mutations such as S741T increased ANO1 calcium sen-
sitivity and rendered ANO1 calcium gating voltage-indepen-
dent, demonstrating a critical role of the re-entrant loop in cou-
pling calcium and voltage sensitivity of ANO1 and hence in
regulatingANO1 activation. Our data present the first unbiased
and comprehensive study of the structure-function relationship
of ANO1. The novel ANO1mutants reported have diverse func-
tional characteristics, providing new tools to study ANO1 func-
tion in biological systems, paving the path for a better under-
standing of the function of ANO1 and its role in health and
diseases.
Despite their critical functions in cells, themolecular identity
of calcium-activated chloride channels (CaCCs)2 had been
enigmatic for many years, but in 2008, three independent
laboratories identified ANO1 (anoctamin 1, also known as
TAOS2, DOG1, ORAOV2, and TMEM16A) as the first CaCC
(1–4). ANO1 is widely expressed in secretory epithelia (5–8),
as well as in a variety of other cell types, including smoothmus-
cles and sensory neurons (6, 9, 10). ANO1exhibits an important
function in regulating airway fluid secretion, gut motility,
secretory functions of exocrine glands, renal function, (vascu-
lar) smooth muscle contraction, and nociception (8, 10, 11).
The physiological relevance of ANO1 is further underscored by
several disease states associated with ANO1 dysfunction,
including asthma, gastroparesis, hypertension, rota-virus-in-
duced diarrhea, polycystic kidney disease, as well as its high
expression and amplification in various cancers (12–17).
ANO1 belongs to the family of anoctamins that includes 10
members (ANO1–10) (18). Besides ANO1, only ANO2 and
ANO6 have conclusively been shown to evoke the appearance
of calcium-activated chloride current (19, 20). Anoctamins do
not share any significant sequence homology with other known
ion channel proteins, and in the absence of a crystal structure
the prediction of the topology is limited to the methods of
bioinformatics. Hydropathy analysis predicts an eight-trans-
membrane structure with cytoplasmic N and C termini (21),
although this model has recently been questioned (4, 22–24).
In addition to the lack of information aboutANO1’s topology
and structure, the mechanism of ANO1 activation is even less
understood. Although it is well established that ANO1 is acti-
vated by calcium, it is not clear whether calcium directly binds
to the channel or whether auxiliary calcium-binding proteins
(i.e. calmodulin) are needed (24–27). ANO1 lacks “classical”
calcium-binding motifs found in other channels. Recently, res-
idues in the third intracellular loop of ANO1 have been pro-
posed to mediate calcium sensitivity of ANO1 (23, 24), and
reconstitution of ANO1 in proteoliposomes has been shown to
be sufficient to recapitulate the biophysical properties of ANO1
(28), suggesting a direct activation by calcium. However, it
remains unclear how calcium binding regulates the activity of
the channel. In the absence of a crystal structure for ANO1,
alternative ways to study the structure-function of ANO1 are
needed.
Here, we report the results of an unbiased approach to inves-
tigate the structure-function relationship of ANO1. By using
a high-throughput, random mutagenesis-based variomics
screen, we generated and functionally characterized a library of
6000 mutants of ANO1. We identified several residues in
* All authors are employees of Novartis Institutes for Biomedical Research.
1 To whom correspondence should be addressed: Novartis Institutes for Bio-
medical Research, 250 Massachusetts Ave., Cambridge, MA 02139. Tel.:
617-871-7209; Fax: 617-871-5783; E-mail: alex.gaither@novartis.com.
2 The abbreviations used are: CaCC, calcium-activated chloride channel; CCH,
carbachol; pF, picofarad.
THE JOURNAL OF BIOLOGICAL CHEMISTRY VOL. 290, NO. 2, pp. 889–903, January 9, 2015
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc. Published in the U.S.A.
JANUARY 9, 2015•VOLUME 290•NUMBER 2 JOURNAL OF BIOLOGICAL CHEMISTRY 889
This is an Open Access article under the CC BY license.
ANO1 that when mutated significantly changed the functional
properties of ANO1 inmultiple ways, by causing the channel to
be inactive at high calcium levels, by inducing activity even at
low calcium concentrations, or by affecting the intracellular
trafficking and localization. In summary, our data provide the
first unbiased and comprehensive study of the structure-func-
tion relationship of ANO1. The newly identified, functionally
diverse group of ANO1 mutants provides new tools for the
study ofANO1 function in biological systems,whichwill lead to
a better understanding of the function of ANO1, its physiolog-
ical function, and therapeutic potential.
EXPERIMENTAL PROCEDURES
Error-prone PCR-mediatedMutagenesis—Error-prone PCR-
mediated mutagenesis was performed using the GeneMorph II
random mutagenesis kit (Stratagene). Briefly, 500–1000 ng of
plasmid DNA (pcDNA3.1-ANO1(abc)-His) was mutagenized
by PCR according to the manufacturer’s protocol using the
following primers: ANO1-N-fw, 5-GGGAGACCCAAGCTG-
GCTAGTTAAGC-3, and ANO1-N-rev, 5-CGCCACTGTG-
CTGGATATCTGCAG-3; ANO1-C-fw, 5-GCAGATGCGG-
CTGAACTACAGATGG-3, and ANO1-C-rev, 5-TCTTCC-
TCGAAGCCGGTCAGGTC-3. PCR products were separated
by gel electrophoresis and purified using a gel extraction kit
(Qiagen). After restriction enzyme digest (HindIII/PpuMI for
N-terminal and PpuMI/EcoRI for C-terminal library), theDNA
was purified with a PCR purification kit (Qiagen) and cloned
into the parental vector at equivalent positions (pcDNA3.1-
ANO1(abc)-His). Mutagenized DNA was transformed into
Escherichia coli DH5 maximum efficiency (Invitrogen), and
two libraries with around 3000 mutants each were prepared as
described previously (29). The 96-well plates containing nor-
malizedmutant DNA (40 ng/l) were re-arrayed into 384-deep
well bar-coded bioassay plates (Greiner Bio-One) by transfer-
ring 62.5l (2.5g ofDNA) ofmutant plasmidwith aMiniTrak
robot (PerkinElmer Life Sciences) into the assigned 384-well
plate coordinates. Each 96-well plate was stamped four times
on a 384-well plate to allow for the parallel testing of multiple
assay conditions on the same plate. In total, 66 unique 384-well
plates (33 plates per library, 6000 mutants total) containing
an individual clone within each well were generated. All plates
were stored at20 °C.
Next Generation Sequencing—All library constructs were
pooled, and the genomic library was prepared, sequenced, and
analyzed as described previously (29). Nonbiased assessment of
codon usage was calculated by dividing the total mutations
across the coding sequence by the potential mutations. All
potential codons were then determined based on the three
alternative bases at each location, assuming one mutation per
codon. The data have been deposited in the NCBI SRA data-
base, bioproject ID PRJNA261442.
Cell Culture and Transfection—CHO cells (Invitrogen) were
cultured in DMEM/F-12; HEK293TN (Invitrogen) and
HEK293 cells stably expressing the H148Q/I152L variant of
YFP (generated as described in Ref. 30) were maintained in
DMEM supplemented with fetal bovine serum (10% v/v) at
37 °C, 5% CO2. For screening, cells were harvested using tryp-
sin/EDTA buffer and seeded on multiwell plates. Forward
transfection of cells with the mutant library was performed in
poly-D-lysine-coated 384-well black clear bottom plates (BD
Biosciences) using FuGENE6 (Promega) according to the man-
ufacturer’s instructions. Briefly, 1l (40 ng) of cDNA library or
wild-type ANO1, mixed with 0.12 l of FuGENE 6 in a total of
20l, was added to the eachwell of cells using a Biomek robotic
workstation. Cells were then incubated for a total of 2 days at
37 °C, 5% CO2. After 1 day, the media from the plates were
replaced with 65 l of fresh growth media. Follow-up experi-
ments were performed in a 96-well format. Cells in collagen-
coated 96-well black clear bottom plates (Corning Glass) were
transfected as described above using 160 ng of DNA and 0.48l
of FuGENE 6 in a total volume of 20 l of OptiMEM per well.
For the analysis of protein expression, cells were seeded and
transfected in 6-well plates using 1 g of DNA and 3 l of
FUGENE 6.
Generation of Stable Cell Lines—The sequence for human
ANO1 (abc-splice form) was cloned into an HIV-based lentivi-
ral vector with puromycin resistance gene (pEZ-ANO1(abc)-
Lv105, GeneCopoeia). For virus packaging, pEZ-ANO1(abc)-
Lv105 was cotransfected with vira-power lentiviral packaging
mix (Invitrogen) into HEK293TN cells according to the man-
ufacturer’s protocol. CHO cells were infected with lentivirus in
the presence of 10 g/ml Polybrene (Applied Bioanalytical).
Cells stably expressing ANO1 were selected with 10 g/ml
puromycin. Stable cell pools were seeded into 96-well plates
aiming for single cells by serial dilution, and two identical plates
were prepared by splitting the cells after 10 days. One plate
was fixed and stained for ANO1 using an anti-His antibody as
described. The clones with the highest expression of ANO1
were selected from the second plate, expanded, and established
as a stable cell line.
Compounds—CaCCinh-A01 was synthesized in-house.
EGTA-AM was purchased from Calbiochem, and all other
chemicals were purchased from Sigma.
YFP-quench Assay—For the screening of the mutant librar-
ies, transiently transfected HEK293-YFP-cells were washed
once in wash buffer (2 mM KCl, 1 mM CaCl2, 1 mM MgCl2, 135
mMNaCl, 10mMD-glucose, 20mMHEPES, pH7.4), and 40l of
wash buffer was added to each well (Biomek robotic worksta-
tion). The YFP baseline signal was recorded for 30 s on an FDSS
platform using aGFP filter set (excitation 480 nm/emission 540
nm), and 10 l of assay solution (2 mM KCl, 1 mM CaCl2, 1 mM
MgCl2, 350 mM NaI, 10 mM D-glucose, 10 mM HEPES, pH 7.4)
was added containing 500 M carbachol (final concentration
100 M carbachol (EC100)) or an equal amount of DMSO
(unstimulated), andYFP fluorescencewas recorded for 2min (1
measurement/s). Kinetics of YFP-quench were analyzed man-
ually, and mutants were classified as described in the text. For
follow up of single mutants, transiently transfected cells in
96-well plates were washed once in wash buffer, and 80 l of
wash buffer (containing compound or DMSO as indicated) was
added to eachwell. After 10min, the plates were analyzed on an
EnVision plate reader with a fluid handling systemmodule and
a GFP bottom read filter module (excitation 485 nm/band
width 14 nm, emission 535 nm/bandwidth 25 nm, bottommir-
ror D505 FITC). Baseline YFP signal was measured for 3 s
before 20 l of assay solution containing 500 M carbachol
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(final concentration 100 M carbachol (EC100)), or an equal
amount of DMSO (unstimulated) was injected per well, and
YFP fluorescencewas recorded for 30 s (1measurement/s). YFP
fluorescence recordings were normalized for the initial back-
ground-subtracted average fluorescence. The relative quench
was calculated as the difference between the initial fluorescence
and the residual YFP fluorescence at the end of the measure-
ment (30 s) andwas used to compare differentmutants (relative
activity).
Site-directed Mutagenesis—Single amino acid mutants were
generated by site-directed mutagenesis (Q5 mutagenesis kit,
New England Biolabs) according to the manufacturer’s proto-
col using pBM-ANO1(abc)-His or pEZ-ANO1(abc)-Lv105 as a
template. Primerswere designed using theNEBaseChanger on-
line tool (New England Biolabs) and were synthesized by Inte-
grated DNA Technologies. Sequences are available upon
request. Maxi-preps (Qiagen) were performed for all mutants.
The introducedmutation was confirmed by Sanger sequencing
of the complete coding region of ANO1 (GeneWiz).
High-Content Image Analysis of ANO1 Expression Level—
Screening plates were fixed with 4% paraformaldehyde imme-
diately after analysis and were stored at 4 °C. Plates were
washed twice in PBS and were incubated in blocking solution
(3% (w/v) BSA, 0.3% Triton X-100 in PBS) for 1 h at room
temperature. Primary antibody (anti-His, D3I1O, Cell Signal-
ing) was added, and plates were incubated overnight at 4 °C.
Plateswerewashed twice in PBS, andAlexa660-conjugated sec-
ondary antibody was added in blocking buffer for 1 h at room
temperature. Nuclei were stainedwithDAPI. Imagingwas con-
ducted using a WiScan automated microscope (Idea Bio-Med-
ical) with a 10  0.4 NA UPLSAPO objective (Olympus),
recording 16 fields/well. Image analysis has been performed as
described previously (31). In brief, fluorescence intensitieswere
quantified on a cell by cell basis. For this, a mask defining the
nuclear and cellular regions was applied. For the analysis of the
screening plates, individual staining intensities were normal-
ized to the average staining intensity of each plate, and the three
inactive clones with the highest expression (75% of the aver-
age staining intensity of the plate) were picked.
Confocal Microscopy—Cells were grown on collagen-coated
glass coverslips, fixed with 4% paraformaldehyde, and stained
as described above and using an Alexa594-conjugated second-
ary antibody. Coverslips were mounted in VectaShield (Vector
Laboratories), and cells were acquired on a laser scanning con-
focalmicroscope (LSM510Axiovert 200M,Carl Zeiss). A 63
1.4 NA oil immersion objective was used for imaging with the
pinhole diameter set for 1-m optical z-sections. 512  512
pixel images were collected with the ZEN software package
(Carl Zeiss) with an x,y resolution of 0.28 m/pixel. z-stacks
were recorded with a size increment of 0.5 m. For each set of
samples, the laser intensity and detector gain were set for the
most intensely stained specimen such that there was no satura-
tion, and all other samples were imaged at the same settings.
Images were exported to Adobe Photoshop for figure prepara-
tion. Images were cropped to show a representative field of
cells using the middle section of each z-stack, and they orig-
inated from the same respective experiment. All focus, con-
trast, and brightness settings remained constant during
imaging preparation.
Western Blotting—Immunoblotting was performed as de-
scribed previously (32). ANO1 was detected using an anti-
ANO1 antibody (SP31, Abcam). Tubulin served as a loading
control.
Immunoprecipitation—3  106 HEK293-YFP cells were
plated per 10-cm dish, allowed to adhere overnight, and were
transfected with a total of 6 g of DNA using 18 l of FuGENE
6. Cells were harvested 48 h after transfection and lysed in RIPA
buffer (Cell Signaling). 1 mg of lysate was incubated with 40
l of anti-FLAGM2 beads (Sigma) or 40 l of Ni-NTA-coated
beads (Invitrogen) for 1 h at 4 °C. Proteins bound to the beads
after washing were eluted in Laemmli buffer for 10min at 70 °C
and analyzed by immunoblotting.
Electrophysiology—Whole-cell voltage-clamp recordings
were made using the QPatch planar patch clamp system
(Sophion BioSciences, operated according to themanufactu-
rer’s specification) by testing cells stably expressing the indi-
cated lentiviral constructs or cells transiently infected with
BacMam virus (33), as described previously (32). Trypsin-har-
vested cells were resuspended in serum-free medium contain-
ing 1 mg/ml trypsin inhibitor. Gigaseal formation, whole-cell
configuration, and series resistance compensation were estab-
lished at room temperature (21–23 °C) using QPatch software.
The extracellular recording solution contained the following
(inmM):N-methyl-D-glucamine (130), EGTA (10), HEPES (10),
MgCl2 (1), CaCl2 (6), sucrose (45), pH 7.3 (adjusted with HCl).
The intracellular solution contained the following (in mM):
N-methyl-D-glucamine (130), EGTA (20), HEPES (10), MgCl2
(1), 1,2-bis(2-aminophenoxy)ethane-N,N,N,N-tetraacetic
acid (10),Mg-ATP (2), CaCl2 (varying levels), pH 7.25 (adjusted
withHCl; osmolarity adjusted to 320with sucrose). CaCl2 addi-
tionswere calculated to achieve the free [Ca2]i levels indicated
in the figures as described previously (29). CaCCinh-A01 was
used from 30mM stock in 100% DMSO and diluted in extracel-
lular solution (1.1–100 M) maintaining constant 0.3% DMSO
throughout. For evaluating the whole-cell conductance (G),
voltage steps of 1-s duration were given from a holding poten-
tial of70 mV to voltages between70 and70 mV or100
and260mV in 10- and 20-mV steps, respectively, followed by
a step to70mV to observe tail currents. The extended voltage
range was necessary to approach maximal conductances and
enabled us to fit the obtained data. The conductance was cal-
culated from tail currents at 70 mV as G  I/(Vm  ECl),
where I is the peak tail current; Vm is the pulse voltage, and ECl
is the equilibrium potential for chloride for our recording con-
ditions. To analyze the [Ca2]i dependence of ANO1 activation
at different voltages, we have varied the [Ca2]i from 30 nM up
to 10 M. The dependence of G on [Ca2]i was fitted at each
voltage by the Hill equation: G Gmax[Ca2]inH/([Ca2]inH
EC50nH), where EC50 is the [Ca2]i at which half-maximal acti-
vation occurred and nH is the Hill coefficient. To analyze the
voltage dependence of ANO1 activation, the normalized con-
ductance (G/Gmax) at a given [Ca2]i was plotted against the
voltage of the pre-pulse, and a Boltzmann equationwas fitted to
the data:G/Gmax 1/(1 exp(z(V1⁄2V)F/RT)), where z is the
equivalent gating charge associated with voltage-dependent
Re-entrant Loop Regulates ANO1 Channel Activation
JANUARY 9, 2015•VOLUME 290•NUMBER 2 JOURNAL OF BIOLOGICAL CHEMISTRY 891
channel opening; V is the membrane potential; V1⁄2 is the mem-
brane potential producing half-maximal activation; F is the Far-
aday constant; R is the gas constant; and T is the absolute tem-
perature. The maximum conductance Gmax was estimated
from the fit of the voltage dependence ofG at 1M free [Ca2]i,
and G at each [Ca2]i was then normalized to the same Gmax.
To evaluate the deactivation kinetics, the voltage protocol
included a single 1-s pre-pulse at100mV followed by 4-s long
voltage steps between 120 and 80 mV in 20-mV incre-
ments. Single exponential functions, A  Bexp(t/deact)
(whereA andB are parameters representing the plateau and the
span of the current decay, and deact is the time constant
describing the deactivation time course), were fitted to tail cur-
rents at each potential. For CaCCinh-A01 experiments, a 1.5-s
duration pulse at 70 mV from and returning to a holding
potential of70 mVwas combined with a voltage ramp proto-
col that changed themembrane voltage continuously from90
to70 mV over 1.5 s. Current amplitudes recorded at the end
of the depolarizing step at70mV before and after cumulative
applications of increasing concentrations of CaCCinh-A01were
normalized and plotted to evaluate the CaCCinh-A01-mediated
inhibition of ANO1. Data are presented asmeans	 S.E., with n
indicating the number of cells. Student’s unpaired two-tailed t
test was used for statistical analysis, and p 
 0.05 was consid-
ered significant.
RESULTS
Functional Characterization of a High-Throughput Random
Mutagenesis Library for ANO1 Identifies Inactive andConstitu-
tively Active Mutants—Using high-throughput random mu-
tagenesis, we aimed to identify amino acids critical for ANO1
function. We generated two libraries with a total of 6000
mutants of ANO1 (abc-splice form) by error-prone PCR target-
ing the N-terminal half or the C-terminal half of the coding
region for ANO1 (3000 clones were picked for each library).
The quality, coverage, and mutation rate of our mutagenesis
librarieswere analyzed by next generation sequencing (29). The
data revealed a homogeneous coverage of the complete coding
region of ANO1 and an overall mutation rate of 0.78 muta-
tions/kb (Table 1). A YFP-quench assay was used to measure
the activity of the cloned ANO1 mutants. With this assay,
the influx of anions (iodide) in cells expressing a halide-
sensitive mutant of YFP (YFP H148Q/I152L) can be moni-
tored by measuring the quenching of YFP fluorescence (Fig.
1a) (34, 35). HEK293 cells stably expressing YFP-(H148Q/
I152L) were transfected with the ANO1 mutants, and the
rate of YFP quenching was compared with cells transfected
with wild-type ANO1 (ANO1-WT). Because ANO1 activity
depends on the presence of intracellular calcium (1, 3, 4), we
stimulated the cells with the muscarinic receptor agonist
carbachol (CCH) and screened for ANO1mutants that failed
to show CCH-induced quenching of YFP (inactive mutants).
To find mutations that render ANO1 more active at low
calcium levels (herein conferred to as constitutively active
mutants), we measured ANO1 activity in the absence of
CCH and compared the rate of YFP quenching to ANO1-WT
transfected cells. By testing 6000 mutants under unstimu-
lated and CCH-stimulated conditions, we identified a total
of 2683 inactive mutants and 53 constitutively active ANO1
mutants. Only 3589 mutants showed wild-type activity of
ANO1 (active mutants). To exclude inactive mutants that
were caused by nonsense mutations, truncations, or muta-
tions that prevent ANO1 from being expressed, we stained
the screening plates after completion of the YFP assay for
ANO1 using a C-terminal His tag, and expression of ANO1
was quantified by high-content imaging analysis (Fig. 1b).
The 170 inactive mutants of ANO1 with the highest expres-
sion and all 53 constitutively active mutants were sequenced
and compared with the wild-type sequence for ANO1. Align-
ment of the sequences of the 170 inactive mutants identified
132 distinct inactive mutants with a total of360 amino acid
changes targeting 268 amino acid positions, including muta-
tions of residues previously reported to be critical for ANO1
function (Arg-537, Leu-575, Glu-727, Glu-756, and Asp-
760) (1, 23, 24, 36). Furthermore, 25 mutants were found to
have deletions in the coding region for ANO1 and were
excluded from the analysis. Analysis of the sequences for the
53 constitutively active mutant clones identified 49 distinct
constitutively active mutants for ANO1, with a total of 95
amino acid changes, targeting 68 amino acid positions.
These data highlight the merit of high-throughput random
mutagenesis, coupled to a functional cell-based character-
ization, to discover novel mutations with divergent effects
on ANO1 protein function in a cellular system.
Identification of Novel Mutations That Cause Inactivity of
ANO1—Most of the mutant constructs for ANO1 that scored
in our primary screen showed multiple mutations. To identify
the causative mutation, 177 ANO1 mutants (103/74 mutants
for inactive and constitutively active mutations, respectively)
with single amino acid changes were generated by site-directed
mutagenesis, and their function was tested in the YFP-quench
assay.We identified 52 single amino acidmutations that caused
a decrease in CCH-induced ANO1 activity of 50% as com-
pared with ANO1-WT (Fig. 2a). To analyze whether the muta-
tions had any effect on the expression level of ANO1, we quan-
tified the expression of all 52 inactive ANO1 mutants by using






A3G 51.89 A3G, T3C 52.63
T3C 53.33
G3A 57.33 G3A, C3T 58.27
C3T 59.20
Transversion
A3T 40.78 A3T, T3A 37.80
T3A 35.03
A3C 7.34 A3C, T3G 9.57
T3G 11.65
G3C 10.88 G3C, C3G 10.24
C3G 9.61
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found to be only weakly expressed and were excluded from
further analysis. Calculating the ratio of the activity and expres-
sion level for each mutation allowed us to rank order the
mutants to identify the mutants with the most significant
decrease in relative ANO1 activity (Fig. 2c). Furthermore, the
expression of all mutants was analyzed by Western blotting as
exemplarily shown in Fig. 2d for selected inactive mutants.
ANO1-WT is glycosylated and is detected as a double band,
corresponding to themature and immature form of ANO1 (18,
32). Fourteen out of the 38 inactive mutants with confirmed
ANO1 expression lacked the expression of the upper band for
ANO1, indicative of a lack of maturation likely caused by a
mislocalization of ANO1 in the cell, thus providing an explana-
tion for the lack of activity in the YFP assay. In agreement with
this hypothesis, we analyzed the localization of all ANO1
mutants by high-content imaging, which showed a mainly
intracellular localization of all 14 mutants with an altered
expression pattern in the Western blot (Fig. 2c). Seventeen
mutants were found to be expressed on the plasma membrane.
In addition, we analyzed the subcellular localization for our top
13 inactive mutants with the lowest activity/expression ratio of
ANO1 (ratio 
0.25) by immunofluorescence in HEK293-YFP
cells using confocal microscopy (Fig. 2e). Consistent with the
expression pattern on the Western blot, 8/13 inactive ANO1
mutants were expressed primarily on the plasma membrane,
whereas ANO1-D63G, L254P, A430D, L759P, and L811P were
mainly intracellularly localized, indicating accumulation of
ANO1 in the endoplasmic reticulum/Golgi network of the cells
with little or no expression of ANO1 on the plasmamembrane.
Taken together, we report 38 inactive mutants for ANO1 with
high expression, among which 17 mutants showed localization
to the plasmamembrane. Thesemutants are of particular inter-
est when compared with the previously reported inactive
mutants of ANO1. Although we were able to confirm expres-
sion and a 50% decrease in ANO1 activity for all tested
mutants, only R643E, E724Q, andE727Q showed a double band
pattern of ANO1 on aWestern blot (Fig. 2, f, g, and i).We found
ANO1-R537A, K667E, R886A, K610A, and Q731A to be local-
ized in intracellular compartments of the cells, whereas only
ANO1-R643E, E724Q, and E727Q were expressed on the
plasmamembrane (Fig. 2, h and i). Our data suggest that muta-
tions of ANO1 are directly affecting the biochemical activity of
the channel or the subcellular localization of the protein, both
of which result in loss of ANO1 activity on the plasma mem-
brane. These results highlight the need for a careful character-
ization of inactive ANO1 mutants to distinguish the lack of
activity caused by mutations affecting critical residues for
ANO1 function from mutations causing mislocalization of
ANO1.
Using Inactive Mutants to Probe the Functional Structure of
ANO1—ANO1’s quaternary structure has recently been de-
scribed as a homodimer, and perturbation of dimerization has
been shown to interfere with ANO1’s activity (37–39). How-
ever, it remains unclear whether both ANO1 monomers con-
tribute to the formation of the active pore in the dimer (one-
poremodel) or whether eachmonomer in the dimer on its own
can form an active pore (two-pore model). To address this
question, we cotransfected HEK293-YFP cells with ANO1-WT
and equal amounts of inactive, membrane-localized ANO1
FIGURE 1. Functional characterization of a library of6000 ANO1mutants. a, schematic summary of the principle of the YFP-quench assay. HEK293 cells
stably expressing a halide-sensitive variant of YFP (YFP H148Q/I152L) were transiently transfected with ANO1, and the ANO1-mediated influx of iodide was
analyzedbymeasuringYFP fluorescencebefore andafter stimulationof intracellular calcium releasewithCCH. Exemplarymeasurements are shown.b, relative
staining intensity of ANO1 (normalized to the mean staining intensity of the active ANO1 mutants) in the three experimental groups (positive, wild-type like
activity; CA, constitutive activity; inactive, no activity) and the subset of inactivemutants selected for further characterization in subsequent experiments. Each
box represents the median and 25th/75th percentiles;whiskers depict the minimum and maximum.
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mutants (ANO1-IA) and measured ANO1 activity in the YFP-
quench assay. In the one-pore model where both ANO1 units
contribute to the active pore, the coexpression of inactive
ANO1 should result in a decrease in ANO1 activity, i.e. a
dominant-negative effect, because a heterodimer between
ANO1-WT and ANO1-IA is expected to be inactive. On the
contrary, in the two-pore model, coexpression of inactive
ANO1 is not expected to result in a decrease in ANO1 activity
given that the ANO1-WT part in an ANO1-WT/ANO1-IA
heterodimer can still form an active pore. Cell were either
transfected with equal amounts of WT plasmid and vector or
with equal amounts WT plasmid and ANO1-IA. As shown in
Fig. 2j, coexpression of ANO1-IA did not result in a decrease in
ANO1 activity hence supporting a two-pore model. Coimmu-
noprecipitation experiments showed that the inactive mutants
dimerized and interacted with ANO1-WT at similar levels as
the WT (Fig. 2k). Hence, our results support a two-pore qua-
ternary structure model for ANO1, where each molecule of
ANO1 functions as an independent pore.
Functional Characterization of Constitutively Active Mu-
tants of ANO1—Our primary screen identified 49 mutants
(with a total of 95 mutations) of ANO1 with significant activity
under nonstimulated (low calcium) conditions. Out of the 74
single amino acid mutants we generated by site-directed
mutagenesis, 28 mutants showed a significant increase in
activity in the YFP-quench assay under unstimulated condi-
tions as well as after stimulation with CCH as compared with
ANO1-WT (Fig. 3a). Four of the mutants (ANO1-I618T,
T736N, S741N, and S741T) demonstrated an activity level
under unstimulated conditions that was above that of
ANO1-WT at maximal stimulation, representing a hyperac-
tive, constitutively active phenotype of ANO1 (Fig. 3b). All 28
mutants were expressed at similar levels as the wild-type and
showed the characteristic double band pattern for ANO1 on a
Western blot and localized to the plasma membrane (data not
shown). Notably, 8 of the 28 mutants mapped to a predicted
transmembrane domain of ANO1 (transmembrane domain 6,
TM6), suggesting an important role of this region for the regu-
lation of ANO1 activity. Whole-cell recordings of the chloride
conductance of an exemplary subset of our constitutively active
mutants at 180 nM free intracellular calcium concentrations
further demonstrated the high activity of the mutant channel
under low intracellular calcium conditions, which is not suffi-
cient to activate the WT channel under physiological condi-
tions (Fig. 3c).
Using Constitutively ActiveMutants to Study theMechanism
of Action of the ANO1 Inhibitor CaCCinh-A01—CaCCinh-A01
inhibits ANO1-dependent chloride conductance. However,
direct binding of CaCCinh-A01 to ANO1 has not been shown,
and its mechanism of action remains elusive. We tested the
effect of CaCCinh-A01 on our constitutively active mutants
and found that CaCCinh-A01 was less effective in inhibiting
ANO1mutants with constitutive activity as compared with the
wild-type channel (Fig. 4, a and b). Both channel types demon-
strated a reduction in inhibitor efficacy and potency at higher
levels of intracellular calcium (Fig. 4c). We hypothesized that
the reduction in inhibitor efficacy and potency is more pro-
nounced in the mutants due to their increased calcium sensi-
tivity and thus higher activity, rather than mutation-induced
disruption to the inhibitor-binding site. If CaCCinh-A01 is less
effective in inhibiting the active channel, an increase in the frac-
tion of ANO1 present in the inactive conformation should
result in an increased sensitivity to CaCCinh-A01. To test this
hypothesis, we compared the IC50 value of CaCCinh-A01 for
inhibiting the activity of ANO1-S741T under unstimulated
(inactive  active conformation) and stimulated conditions
(active conformation). ANO1-S741T showed an 4-fold
increase in sensitivity to inhibition by CaCCinh-A01 under
unstimulated conditions, corroborating our hypothesis that
CaCCinh-A01 preferentially binds and stabilizes the inactive
form of ANO1 (Fig. 4b). The decrease in sensitivity of ANO1-
S741T under stimulated conditions was not caused by compe-
tition with calcium, as co-treatment with EGTA did not affect
the sensitivity of ANO1-S741T to inhibition by CaCCinh-A01
(Fig. 4d). Whole-cell voltage clamp measurements of ANO1-de-
pendent chloride currents after treatment with CaCCinh-A01
showed that ANO1-S741Twas not completely inhibited by CaC-
Cinh-A01 in the tested concentration range (Fig. 4c). These data
are in full agreementwith thehypothesis thatCaCCinh-A01binds
preferentially to a less active channel state.
ANO1-S741T Shows an Increased Sensitivity to Calcium—
Mutation of Ser-741 to Thr (ANO1-S741T) resulted in the
strongest activation of ANO1 in the YFP assay under unstimu-
lated conditions with only a minor additional increase in activ-
ity after stimulation with CCH, suggesting an increase in sensi-
tivity to intracellular calcium (Fig. 3b). Intrigued by the
FIGURE 2. Characterization of inactive ANO1mutants. a, activity of selected single aminomutants of ANO1measured in a YFP-quench assay after stimula-
tionwith CCH. Datawere normalized to the activity of ANO1-wild type (wt)mean	 S.E. n 4. b, comparison of the activity (as determined in a) and expression
level (measured by high-content imaging) of 52 inactive ANO1 mutants. Data were normalized to the respective signal of ANO1-WT (mean	 S.E., n 4). c,
summary of the characterization of inactive mutants. The activity/expression ratio was calculated by dividing the relative activity with the relative expression
level. The expression pattern was analyzed by Western blotting and the localization by high-content imaging. d, Western blot analysis of selected inactive
ANO1 mutants (act/expression ratio
0.25). Arrows indicate the two distinct bands detected for ANO1. Tubulin served as a loading control. Representative
images are shown. Image has been cropped at indicated position (dashed line). e, immunofluorescence analysis of ANO1 expression and localization (anti-His,
red) in HEK293-YFP cells (YFP expression, green), nuclear stain (DAPI, blue). Representative confocal images are shown. The upper panel depicts the signal for
ANO1 in gray scale. Scale bar, 20 m. f, comparison of the activity (YFP-quench assay) and expression level (high-content imaging) of previously described
inactive ANO1mutants. Data were normalized to the respective signal of ANO1-WT and are presented as themean	 S.E. of4 experiments. g,Western blot
analysis of inactive ANO1 mutants previously described in the literature. vec, vector. h, immunofluorescence analysis of ANO1 expression and localization of
previously described inactive ANO1 mutants as described in e. i, summary of the characterization of inactive mutants previously reported in the literature. j,
activity of ANO1-WT in the YFP-quench assay when coexpressed with equal amounts of vector, wild type, or the indicated inactive mutants. Data were
normalized to the activity of ANO1-WT cotransfected with equal amounts of empty vector and are presented as the mean 	 S.E. of 8 measurements. k,
coimmunoprecipitation (IP) analysis of the hetero-oligomerization of ANO1-WT and inactive mutants of ANO1. HEK293-YFP cells were transfected with equal
amounts of the indicatedmutants (His-tagged) andANO1-WT (FLAG-tagged), andANO1was precipitated from the lysate usingNi-NTAor anti-FLAGantibody-
coated beads, and the amount of copurified ANO1-WT or inactive mutant, respectively, was determined by Western blotting.
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significance of the effect caused by this rather conservative
amino acid substitution, we investigated the effect of all possi-
ble amino acid substitutions at Ser-741. With the exception of
S741E and S741W, all mutants were expressed and localized at
the plasma membrane (Fig. 5, a and b). S741E and S741W
showed a significant intracellular accumulation of ANO1
accompanied by a decrease in the expression level for S741E,
providing an explanation for the observed inactivity of these
mutants. In addition to ANO1-S741T and S741N, we found
that substitution of Ser-741with isoleucine or valine (S741I and
S741V) caused a similar constitutive activity of ANO1 under
nonstimulated conditions (Fig. 5c). Correlation of the observed
phenotype under unstimulated conditions with the chemical
properties of the substituting amino acid residues showed that
the constitutively active phenotype was dependent on the size
of the side chain, although there was no correlation to the
charge, hydrophobicity, or polarity of the side chain, suggesting
that Ser-741 plays a critical role in the activation of ANO1 and
when mutated can facilitate conformational changes required
to open the channel, for example by fostering binding of cal-
cium (Fig. 5d). To test whether ANO1-S741T enhances the
activation of the channel by free intracellular calcium, we
recorded the activity of ANO1-S741T after stimulation with
increasing concentrations of CCH in the YFP-quench assay.
Although ANO1-WT showed a robust dose-dependent in-
crease in activity with increasing concentrations of CCH,
ANO1-S741T showed only a minor increase in activity, with
already 90% of wild-type activity under unstimulated condi-
tions (Fig. 5e). Consistent with an increased calcium sensitivity
of ANO1-S741T, treatment with EGTA-AM led to only a
minor decrease in activity under both stimulated and unstimu-
lated conditions, even at concentrations of EGTA-AM that
FIGURE 3. Characterization of constitutively active ANO1mutants. a, activity of selected single aminomutants of ANO1measured in an YFP-quench assay
in the absence of CCH (unstimulated). Data were normalized to the activity of ANO1-WT (mean	 S.E., n 4). b, comparison of the activity (YFP-quench assay)
of 28 constitutively active ANO1 mutants in the absence (unstimulated) and presence of CCH (CCH). Data were normalized to the respective signal of
ANO1-WT (mean	 S.E.,n 4). c,whole-cell voltage clamp recordings of ANO1-mediated chloride currents of the indicatedmutants at 180nM free intracellular
calcium. Voltage steps of 1-s duration were given from a holding potential of70 mV to voltages between70 and70 mV in 10-mV increments, followed
by a step to70 mV. If not otherwise indicated, the scale shown for ANO1-wt applies for all panels.
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blocked the activity of ANO1-WT (Fig. 5f). These data
strengthen the hypothesis that ANO1-S741T exhibits an
increased affinity for or even complete independence on intra-
cellular calcium. To test whether the activity of S741T is inde-
pendent of calcium, we mutated two of the proposed calcium-
binding sites of ANO1. Mutation of either Glu-727 or Glu-724
to glutamine completely diminished the activity of S741T even
under stimulated conditions, suggesting that S741T still
requires calcium to be activated (Fig. 5, g and i). Consistent with
our hypothesis, the whole-cell current recording of ANO1-de-
pendent currents over a large range of membrane voltage
potentials (Vm) and intracellular free calcium concentrations
showed a profound increase in calcium sensitivity for ANO1-
S741T (Fig. 6, a–c). Although there was no activation in the
absence of intracellular free calcium, calcium concentrations as
small as 100 nM activated robust levels of S741T currents that
were reached by the wild-type channel only in the presence of
5-fold higher Ca2 concentrations (ANO1-S741T: 0.60 	
0.07 nS/pF, n 32; ANO1-WT: 0.37	 0.06 nS/pF and 1.03	
0.11 nS/pF at 415 and 590 nM, respectively, n 31 and 44,Vm
60 mV). This occurred despite the ANO1-S741T channel
showing smaller overall maximal conductance density than the
ANO1-WT, 10.8	 0.8 nS/pF,n 21, and 23.1	 2.7 nS/pF,n
10, respectively. Determination of the EC50 value of calcium-
dependent activation of ANO1 at different holding potentials
showed a left shift of the curves for S741T as compared with
ANO1-WT (Fig. 6c). Remarkably, although ANO1-WT
showed the characteristic voltage-dependent increase in cal-
cium sensitivity, the EC50 value of calcium remained constant
for ANO1-S741T for all tested Vm values, indicating a decou-
pling of calcium sensitivity from voltage dependence in ANO1-
S741T. Consistent with this hypothesis, we found that in con-
trast to the wild-type channel, the Hill coefficient (nH) for
ANO1-S741T, indicative of the cooperativity of Ca2 binding,
was not dependent on voltage (Fig. 6d). Thus, the mutation
renders the Ca2 binding of ANO1-S741T voltage-independ-
ent. Conductance of ANO1-S741T was still modulated by Vm
values, although this dependence was significantly altered
when compared with ANO1-WT. The S741Tmutation caused
a left shift in the normalized conductance G/Gmax versus Vm
curves at low Ca2 concentrations and surprisingly, altered the
slope (Fig. 6, e and f).We looked at the two parameters resulting
from the Boltzmann fit of theG-V relations,V1⁄2, themembrane
potential producing half-maximal activation representing the
conformational energy associated with voltage-independent
channel opening, and z, the equivalent gating charge associated
with voltage-dependent channel opening (Fig. 6, e and f).
ANO1-S741T showed a decrease in V1⁄2, suggesting an in-
creased ability of Ca2 to reduce the activation energy required
for the channel to open. TheVm sensitivity (z) of ANO1-S741T
was calcium-independent as reported previously for ANO1-
WT (40), but it was reduced by one-fourth as compared with
the wild type, suggesting the mutation disrupts either the mov-
ing charge or the electrical field inwhich the charge that confers
FIGURE 4. CaCCinh-A01 sensitivity of ANO1mutants. a, residual activity of all 28 constitutively active single aminomutants of ANO1 as compared with WT
after treatment with 10 M CaCCinh-A01 measured in a YFP-quench assay in the presence of CCH. Data were normalized to the activity of the DMSO-treated
ANO1-WT (wt). Each box represents the median and 25th/75th percentiles of4 measurements; whiskers depict the minimum and maximum. b, activity of
ANO1-WT and ANO1-S741T in the YFP-quench assay after treatment with the indicated concentrations of CaCCinh-A01. Data present mean 	 S.E. of 3
measurements. c, CaCCinh-A01 concentration-dependent inhibition of ANO1 currents at the indicated range of calcium concentrations, determined by
whole-cell voltage clamp recordings (70 mV). Data were normalized to basal currents in the absence of inhibitor (mean	 S.E. of3). d, activity of ANO1-
S741T in the YFP-quench assay after treatment with the indicated concentrations of CaCCinh-A01 and EGTA-AM or DMSO. Data present mean	 S.E. of3
measurements.
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FIGURE 5.Mutation of ANO1-Ser-741 to Thr facilitates activation of ANO1. a,Western blot analysis Ser-741-ANO1 mutants. The arrows indicate the two
distinct bands detected for ANO1. Tubulin served as a loading control. Representative images are shown. b, immunofluorescence analysis of Ser-741-ANO1
mutant expression and localization (anti-His, red) in HEK293-YFP cells (YFP expression, green), nuclear stain (DAPI, blue). Representative confocal images are
shown. The upper panel depicts the signal for ANO1 in gray scale. Scale bar, 20 m. c, comparison of the activity (YFP-quench assay) of ANO1 mutants with
alternative amino acid changes at Ser-741 in the absence (unstimulated) and presence of CCH (CCH). Data were normalized to the respective signal of
ANO1-WT (mean	 S.E., n 4). vec, vector. d, relative activity of each Ser-741 mutant is plotted as a function of side chain surface area. Letters indicate the
substituted amino acid. e, comparison of the activity of ANO1-WT and ANO1-S741T at different concentrations of CCH (YFP-quench assay). Data were
normalized to the maximal activity of ANO1-WT (mean	 S.E., n 4). f, sensitivity of ANO1-WT and ANO1-S741T to inhibition with EGTA. Activity of ANO1-
WT/-S741T in theYFP-quenchassaywasmeasuredafter treatmentwith the indicated concentrationsof EGTA-AM in thepresenceor absenceofCCH.Datawere
normalized to the activity after treatment with DMSO and are presented as themean	 S.E. of4 experiments. g, relative activity of indicated doublemutant
of ANO1-S741T in the YFP-quench assay as compared with ANO1-S741T and ANO1-WT. h,Western blot analysis of ANO1-S741Tmutants. The arrows indicate
the two distinct bands detected for ANO1. Tubulin served as a loading control. Representative images are shown. i, immunofluorescence analysis of ANO1-
S741T mutants as described in b.
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voltage sensitivity is moving. Furthermore, we found that
S741T showed a drastic elongation of the deactivation time
(Fig. 6g). These data are consistent with S741T facilitating the
active conformation of the channel and Ser-741 regulating the
conformational changes coupling calcium binding and voltage
sensitivity of ANO1.
DISCUSSION
N Terminus of ANO1 Regulates Trafficking to the Plasma
Membrane and Affects Channel Activity—Using an unbiased,
high-throughput randommutagenesis approach, we have iden-
tified several novel single amino acid mutations in ANO1 that
affected ANO1 activity, trafficking, and subcellular localization
(Fig. 7). Among the inactive mutants of ANO1 with confirmed
expression of ANO1, we found multiple mutations to interfere
with the localization of ANO1 to the plasma membrane. Point
mutations in the intracellular domains of ANO1 can point to
the existence of trafficking motifs. The N terminus of ANO1
has been described to be critical for the expression and traffick-
ing of ANO1 to the plasma membrane (41–44). We identified
four mutations in the N terminus that prevented ANO1 from
being trafficked to the plasma membrane, opening up the pos-
sibility that these residues contribute to a noncanonical traf-
ficking motif in ANO1 and that additional regulatory proteins
bind theN terminus and are involved in regulating trafficking of
the channel. Our data support the hypothesis that the N termi-
nus of ANO1 is critical for localization of ANO1 to the plasma
membrane. Furthermore, we identified two inactive mutants
withmutations in theN terminus of ANO1 that were expressed
on the plasma membrane. Mutations in the same N-terminal
region of ANO1 caused constitutive activity of the channel and
suggest that besides its role in ANO1 trafficking theN terminus
of ANO1 is also involved in the regulation of channel gating.
Mutations in the Transmembrane Domains and C Terminus
of ANO1—With the exception of mutations in the C and N
terminus, all identified constitutively active mutations map to
the predicted transmembrane domains of ANO1, pointing to a
contribution of all transmembrane domains to the formation of
an active channel. A high number of inactive mutations in the
transmembrane domains of ANO1 identified in our screen also
showed a defect in channel trafficking and expression. This
observation demonstrates the technical difficulties in studying
functional domains that are highly sensitive to misfolding and
highlight the value of our gain-of-function and constitutively
active mutants of ANO1 as a new tool to study the processes
leading to ANO1 activation.
Interestingly, we found a cluster of inactive mutations in the
last extracellular domain of ANO1, a region that has not been
implicated in regulation of channel activity before. We did not
find these mutations to affect the glycosylation or localization
of ANO1, suggesting residues 831–836 directly affect channel
FIGURE 6.Electrophysiological characterizationofANO1-S741T. a, representativewhole-cell current traces recorded for ANO1-WTandANO1-S741T at 415
nM intracellular free calcium. Voltage protocol as shown in the figure. b, normalized conductance (G/Gmax) of ANO1-WT and ANO1-S741T. G has been
normalized to the individual maximal conductances at the specified voltage. c, EC50 value of the calcium-dependent activation of ANO1-WT and ANO1-S741T
at the indicated membrane potentials. EC50 values were obtained from fitting of the mean [Ca
2]iwhole-cell conductance response relationship with the
Hill-Langmuir equation. Themean conductance at agivenpotential and [Ca2]iwasobtainedby averaging conductancesmeasured inn4–50andn4–64
cells for ANO1-WT and ANO1-S741T, respectively. d, Hill coefficient across a range of membrane potentials from the same fit as described in a. e, plot of the
estimated membrane potential producing half-maximal activation (V1⁄2) of ANO1-WT/S741T versus the concentration of intracellular free calcium. V1⁄2 was
obtained from fitting a Boltzmann equation to the voltage dependence of normalizedwhole-cell conductance at a given [Ca2]i. Themaximum conductance
Gmax was estimated from the fit of the voltage dependence of G at 1M free [Ca
2]i, and G at each [Ca
2]iwas then normalized to the same Gmax. n 9–45. f,
plot of the estimated gating charge (z) associated with voltage-dependent channel opening of ANO1-WT/S741T versus the concentration of intracellular free
calcium. Fitting of data as described in e. g, kinetic analysis of the deactivation timeof ANO1-WT/S741T. Tail currentswere fitted to single exponentials, and the
time constants were plotted versusmembrane potential. n 5–15. **, p
 0.01; ***, p
 0.001.
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activation. Further studies are needed to explore the function of
the last extracellular domain of ANO1 in channel activation.
ANO1 Mutants as a Tool to Study the Function of ANO1 in
Biological Systems—The variety of functional mutations in
ANO1 reported in this study introduces novel tools to study the
function of ANO1 in biological systems. Here, we used our
newly identified mutants to probe the functional structure of
ANO1 and to investigate the mechanisms of action of a small
molecule inhibitor of ANO1.ANO1has been described to form
homodimers, and dimerization has been found to be critical for
ANO1 function (37–39). By using inactive plasma membrane-
expressed mutants of ANO1, we demonstrate a 2-pore model
for ANO1, in which each monomer of ANO1 in a dimer con-
stitutes a separate pore, similar to the quaternary structure of
CLC channels (45, 46). Furthermore, using our constitutively
activemutants as a tool, we showed that CaCCinh-A01 inhibits
ANO1 by interacting with and potentially stabilizing the inac-
tive state of ANO1. Alternatively, the conformational changes
leading to activation of ANO1 induced by calciumormutations
could prevent CaCCinh-A01 from binding. The data presented
in this study are consistent with both proposed models. With-
out the precise knowledge of the binding site of CaCCinh-A01
in ANO1, further studies are necessary to elucidate the mech-
anism of CaCCinh-A01-dependent inhibition of ANO1 in
more detail. These results highlight the value of ANO1mutants
as a tool for investigatingANO1 channel function and its role in
biological systems.
ANO1 Mutants Support the Elucidation of the Function
of Anoctamins in Health and Disease—Members of the
anoctamin gene family have been linked to human disease.
Although no disease-causing mutations in ANO1 have yet
been identified, mutations in ANO3, ANO5, and ANO10
have been associated with human genetic diseases. Mutation
of Trp-490 in ANO3 has been identified to cause a dominant
form of craniometrical dystonia (47). Our screen identified a
mutation of the corresponding conserved residue in ANO1
(ANO1-W449R), which leads to a loss of function accompa-
nied by a decrease in expression and mislocalization of
ANO1. ANO5 was found to be mutated at Asp-81 (D81G) in
a patient with limb girdle muscular dystrophy type 2L, and
mutations of ANO5-Ile-865 was reported in a patient with
anoctaminopathy (48, 49). Mutations at the homolog resi-
dues in ANO1 (Asp-63/Ile-919) caused a loss of function and
mislocalization of ANO1. Similarly, mutation of ANO10
(L510R) has been identified to cause an autosomally reces-
sive form of cerebellar ataxia (50), and we foundmutations at
the corresponding highly conserved residue in ANO1 (Leu-
737) to cause increased constitutive activity of ANO1.
Although we are only beginning to understand the function
of anoctamins in disease, it is possible that mutations of
FIGURE 7. Functional map of ANO1. a, pictogram showing the localization of all identified inactive (lower panel) and constitutively active (middle panel)
mutantsofANO1 (xaxis, aminoacidpositionofANO1). Each line represents thepositionof amutant. Theupperpaneldepicts thepredicted topologies forANO1
(model 1 isbasedonRefs. 1, 4 andmodel 2 isbasedonRef. 23).Blue, intracellular domain;purple, transmembranedomain; yellow,extracellular domain; red, loop
region with proposed re-entrant loop. b, schematic illustrating the predicted topology of ANO1-abc (23, 24). The proposed calcium-binding sites of ANO1 are
indicated by gray dots, and the location of the newly identified constitutively activemutants and inactivemutantswithmembrane localization are highlighted
with red and black dots, respectively.
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these highly conserved residues across the ANO1 family may
translate to similar functional defects as observed for ANO1,
which may result in the clinical phenotype. Our results high-
light the potential of unbiased characterization of ANO1’s
structure-function to support the elucidation of the function
of other anoctamins in health and disease. Activation of
ANO1 has been discussed to be potentially useful to treat
cystic fibrosis by compensating for the loss of function of
cystic fibrosis transmembrane conductance regulator and by
improving mucociliary clearance (13). Current approaches
to investigate this hypothesis are limited to overexpression
of ANO1-WT paired with stimulation of calcium signaling
to activate the channel or a novel class of small molecules
that can temporarily potentiate ANO1 activity (51). The
constitutively active mutants identified in this study present
novel tools for investigating the function and a potential
therapeutic benefit of ANO1 activation in cystic fibrosis.
Moreover, inhibition of ANO1 activation might be poten-
tially beneficial in the treatment of cancer, asthma, or diar-
rhea (6, 16, 32). Recent screening approaches have identified
several small molecule inhibitors of ANO1 (35, 52, 53). How-
ever, these approaches rely on the activation of ANO1 activity by
secondary stimuli to increase intracellular calcium concentration,
and direct binding of these molecules to ANO1 has not been
shown. Using the constitutively active mutants reported in this
study in such screening experiments would eliminate the need to
engage secondary pathways to activate ANO1 and could aid in
reducing the number of false-positive hits due to inhibition of sec-
ondary pathways.
Newly Identified Mutations Support a Revised Topology of
ANO1—Because of the lack of a crystal structure, predictions of
ANO1’s topology are limited on bioinformatic approaches.
Hydropathy analysis predicts an eight-transmembrane struc-
ture with cytoplasmic N and C termini (21). Whereas most
models consistently predict transmembrane domains 1–5 and
7–8, the predictions for the proposed structure of the region
between transmembrane domains 5–7 are ambiguous (23).
Yang et al. (4) proposed the region following transmembrane
domains 5 to form a re-entrant loop that faces the extracellular
environment (Fig. 7a,model 1). Mutations of three highly con-
served, positively charged residues in this region drastically
changed the ion selectivity of ANO1, prompting the authors to
suggest the region around the re-entrant loop (amino acids
642–672) to constitute the pore of the channel (4). This model
has recently been questioned. Yu et al. (23) proposed an alter-
nativemodel for the topology ofANO1, based on epitope acces-
sibility experiments, in which the region between amino acids
653 and 670 completely crosses the membrane to form trans-
membrane domain 6 followed by an intracellular loop with a
partial intercalation into the membrane (Fig. 7a, model 2). In
support of model 2, residues Glu-724/727 and Glu-756/Asp-
760 have been proposed as the calcium-binding sites of ANO1
(23, 24), pointing to an intracellular location. In this model,
amino acids 728–752 are proposed to form a short re-entrant
loop (24). The location of ANO1’s pore, however, remains elu-
sive. Here, we identified a hot spot of mutations in the region
preceding transmembrane domain 7 of ANO1, consisting of a
distinct peak of constitutively activemutations surrounded by a
broader accumulation of inactive mutants. Our data are con-
sistent with a role of this region in calcium binding (inactive
mutations) and point to a critical function of the loop region
(amino acids 728–752 in model 2) in the regulation of channel
activity (constitutively active mutants). In contrast, we identi-
fied only two inactive mutations mapping to the proposed pore
region in model 1 (amino acids 642–672), only one of which
was expressed at themembrane. Given the confirmed coverage
of this region in our mutagenesis approach, the low number of
functional mutations points to only a minor function of this
region in regulating ANO1 activity. Furthermore, we found
previously identified mutations used to map the pore region of
ANO1 to exhibit a severe defect in trafficking and expression,
making the analysis of the functional data challenging. Taken
together, our data suggest an important role of amino acids
721–727 and 756–760 in calcium sensing and hence an intra-
cellular location. Furthermore, our data are consistent with res-
idues 728–752 forming a re-entrant loop and suggest an impor-
tant role of the loop region for the activity of ANO1. Thus, our
findings corroborate the revised topology model of ANO1
(model 2). Our data are consistent with the possibility that
amino acids 728–752 are involved in forming the pore of
ANO1; however, further structural information is needed to
validate this model.
Notably, we did not identify any mutations with functional
effects in regions predicted to constitute a possible binding site
for calmodulin (26, 27, 54), suggesting only a minor role of
calmodulin in the regulation of ANO1 activity in our system, as
already proposed by other studies (25, 28).
S741T Facilitates ANO1 Activation and Renders Its Calcium
Sensitivity Independent of Voltage—Residues Glu-724/727 and
Glu-756/Asp-760 have been proposed as the calcium-binding
sites of ANO1 (23, 24), suggesting a model in which calcium is
sandwiched between those residues, creating a loop between
amino acids 728 and 752 that enters the membrane. Strikingly,
themajority of our constitutively activemutantsmapped to the
predicted re-entrant loop, with Ser-741 mapping half-way
between the two proposed calcium-binding sites. This finding
proposes a model, in which calcium binding to residues Glu-
756/Asp-760 and Glu-727/Glu-724 causes a conformational
change in the loop domain that results in the activation of the
channel and in which the identified constitutively active
mutants of ANO1mapping in the loop region, all on top S741T,
facilitate the calcium-induced conformational changes and
thus the activation of the channel at low calcium concentra-
tions. Characterization of the electrophysiological properties of
ANO1-S741T showed that the mutation resulted in an uncou-
pling of the characteristic voltage and calcium dependence of
ANO1,with calcium inducing channel activationwith the same
potency and cooperativity across the tested voltage range, thus
transforming the channel from a calcium/voltage-gated chan-
nel to a ligand-gated channel. Moreover, S741T facilitated the
voltage-independent step that translates the calcium binding
into channel opening as indicated by the V1⁄2 shifts and
increased the open probability of the channel by decreasing its
deactivation time. The voltage dependence of the calcium sen-
sitivity has been described to result from either voltage-depen-
dent Ca2 binding to the closed state or from voltage-inde-
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pendent Ca2 binding to a channel conformation that itself is
voltage-dependent (55, 56). The observed voltage-independent
activation of ANO1-S741T, accompanied by an increase in cal-
cium sensitivity and the decrease in V1⁄2 and the gating charge,
supports the existence of membrane-potential independent
calcium-binding sites outside of the electrical field and sup-
ports the model that the S741T mutation causes conforma-
tional changes enhancing the accessibility of these binding
sites. The effect of mutations at residue Ser-741 was not
dependent on the polarity, charge, or hydrophobicity of the side
chain, but it showed a dependence on a very narrow size limit of
the side chain. Together with the predicted location of Ser-741
in the center of the re-entrant loop, this observation argues
against a direct involvement of Ser-741 in calcium binding and
rather support for an allosteric effect of residue Ser-741 on reg-
ulating the conformational changes coupling calcium binding
and voltage sensitivity of ANO1.
In summary, our comprehensive study of the structure-func-
tion of ANO1 has identified several residues critical for ANO1
function, localization, and expression. Our study supports the
revised topologymodel ofANO1, demonstrates a critical role of
the re-entrant loop for the activation of the channel, and pro-
vides novel mechanistic insight into the calcium-dependent
gating of ANO1. The collection of functionally characterized
mutations described in this study will aid the investigation of
the molecular mechanisms underlying the activation of ANO1
and its cellular function.
Acknowledgments—We thank Ned Kirkpatrick (Novartis Institutes
for Biomedical Research) for technical assistance with the confocal
microscope and Anne-Lise Glotin for technical assistance with the
YFP-quench assay.
REFERENCES
1. Caputo, A., Caci, E., Ferrera, L., Pedemonte, N., Barsanti, C., Sondo, E.,
Pfeffer, U., Ravazzolo, R., Zegarra-Moran, O., and Galietta, L. J. (2008)
TMEM16A, a membrane protein associated with calcium-dependent
chloride channel activity. Science 322, 590–594
2. Duran, C., Thompson, C. H., Xiao, Q., and Hartzell, H. C. (2010) Chloride
channels: often enigmatic, rarely predictable. Annu. Rev. Physiol. 72,
95–121
3. Schroeder, B. C., Cheng, T., Jan, Y. N., and Jan, L. Y. (2008) Expression
cloning of TMEM16A as a calcium-activated chloride channel subunit.
Cell 134, 1019–1029
4. Yang, Y. D., Cho, H., Koo, J. Y., Tak,M.H., Cho, Y., Shim,W. S., Park, S. P.,
Lee, J., Lee, B., Kim, B. M., Raouf, R., Shin, Y. K., and Oh, U. (2008)
TMEM16A confers receptor-activated calcium-dependent chloride con-
ductance. Nature 455, 1210–1215
5. Gomez-Pinilla, P. J., Gibbons, S. J., Bardsley,M. R., Lorincz, A., Pozo,M. J.,
Pasricha, P. J., Van de Rijn, M., West, R. B., Sarr, M. G., Kendrick, M. L.,
Cima, R. R., Dozois, E. J., Larson, D.W., Ordog, T., and Farrugia, G. (2009)
Ano1 is a selective marker of interstitial cells of Cajal in the human and
mouse gastrointestinal tract. Am. J. Physiol. Gastrointest. Liver Physiol.
296, G1370–G1381
6. Huang, F., Zhang, H.,Wu,M., Yang, H., Kudo,M., Peters, C. J., Woodruff,
P. G., Solberg, O. D., Donne, M. L., Huang, X., Sheppard, D., Fahy, J. V.,
Wolters, P. J., Hogan, B. L., Finkbeiner, W. E., Li, M., Jan, Y. N., Jan, L. Y.,
and Rock, J. R. (2012) Calcium-activated chloride channel TMEM16A
modulates mucin secretion and airway smooth muscle contraction. Proc.
Natl. Acad. Sci. U.S.A. 109, 16354–16359
7. Huang, F., Rock, J. R., Harfe, B. D., Cheng, T., Huang, X., Jan, Y. N., and
Jan, L. Y. (2009) Studies on expression and function of the TMEM16A
calcium-activated chloride channel. Proc. Natl. Acad. Sci. U.S.A. 106,
21413–21418
8. Hwang, S. J., Blair, P. J., Britton, F. C., O’Driscoll, K. E., Hennig, G., Bay-
guinov, Y. R., Rock, J. R., Harfe, B. D., Sanders, K. M., and Ward, S. M.
(2009) Expression of anoctamin 1/TMEM16A by interstitial cells of Cajal
is fundamental for slow wave activity in gastrointestinal muscles.
J. Physiol. 587, 4887–4904
9. Manoury, B., Tamuleviciute, A., and Tammaro, P. (2010) TMEM16A/
anoctamin 1 protein mediates calcium-activated chloride currents in pul-
monary arterial smooth muscle cells. J. Physiol. 588, 2305–2314
10. Cho, H., Yang, Y. D., Lee, J., Lee, B., Kim, T., Jang, Y., Back, S. K., Na, H. S.,
Harfe, B. D., Wang, F., Raouf, R., Wood, J. N., and Oh, U. (2012) The
calcium-activated chloride channel anoctamin 1 acts as a heat sensor in
nociceptive neurons. Nat. Neurosci. 15, 1015–1021
11. Faria, D., Rock, J. R., Romao, A. M., Schweda, F., Bandulik, S., Witzgall, R.,
Schlatter, E., Heitzmann, D., Pavenstädt, H., Herrmann, E., Kunzelmann,
K., and Schreiber, R. (2014) The calcium-activated chloride channel
Anoctamin 1 contributes to the regulation of renal function. Kidney Int.
85, 1369–1381
12. Zhang, C. H., Li, Y., Zhao, W., Lifshitz, L. M., Li, H., Harfe, B. D., Zhu,
M. S., and ZhuGe, R. (2013) The TMEM16A Ca2-activated Cl- channel
in airway smooth muscle contributes to airway hyperresponsiveness.
Am. J. Respir. Crit. Care Med. 187, 374–381
13. Sondo, E., Caci, E., and Galietta, L. J. (2014) The TMEM16A chloride
channel as an alternative therapeutic target in cystic fibrosis. Int.
J. Biochem. Cell Biol. 187, 73–76
14. Britschgi, A., Bill, A., Brinkhaus, H., Rothwell, C., Clay, I., Duss, S., Rebhan,
M., Raman, P., Guy, C. T., Wetzel, K., George, E., Popa, M. O., Lilley, S.,
Choudhury, H., Gosling, M., Wang, L., Fitzgerald, S., Borawski, J., Baffoe,
J., Labow, M., Gaither, L. A., and Bentires-Alj, M. (2013) Calcium-acti-
vated chloride channel ANO1 promotes breast cancer progression by ac-
tivating EGFR and CAMK signaling. Proc. Natl. Acad. Sci. U.S.A.
10.1073/pnas.1217072110
15. Forrest, A. S., Joyce, T. C., Huebner,M. L., Ayon, R. J.,Wiwchar,M., Joyce,
J., Freitas, N., Davis, A. J., Ye, L., Duan, D. D., Singer, C. A., Valencik,M. L.,
Greenwood, I. A., and Leblanc, N. (2012) Increased TMEM16A-encoded
calcium-activated chloride channel activity is associated with pulmonary
hypertension. Am. J. Physiol. Cell Physiol. 303, C1229–C1243
16. Ousingsawat, J., Mirza, M., Tian, Y., Roussa, E., Schreiber, R., Cook, D. I.,
and Kunzelmann, K. (2011) Rotavirus toxin NSP4 induces diarrhea by
activation of TMEM16A and inhibition of Na absorption. Pflugers Arch.
461, 579–589
17. Tanaka, T., and Nangaku, M. (2014) ANO1: an additional key player in
cyst growth. Kidney Int. 85, 1007–1009
18. Pedemonte, N., and Galietta, L. J. (2014) Structure and function of
TMEM16 proteins (Anoctamins). Physiol. Rev. 94, 419–459
19. Pifferi, S., Dibattista, M., and Menini, A. (2009) TMEM16B induces chlo-
ride currents activated by calcium inmammalian cells. Pflugers Arch. 458,
1023–1038
20. Martins, J. R., Faria, D., Kongsuphol, P., Reisch, B., Schreiber, R., and
Kunzelmann, K. (2011) Anoctamin 6 is an essential component of the
outwardly rectifying chloride channel. Proc. Natl. Acad. Sci. U.S.A. 108,
18168–18172
21. Galindo, B. E., and Vacquier, V. D. (2005) Phylogeny of the TMEM16
protein family: some members are overexpressed in cancer. Int. J. Mol.
Med. 16, 919–924
22. Das, S., Hahn, Y., Walker, D. A., Nagata, S., Willingham, M. C., Peehl,
D. M., Bera, T. K., Lee, B., and Pastan, I. (2008) Topology of NGEP, a
prostate-specific cell:cell junction protein widely expressed in many can-
cers of different grade level. Cancer Res. 68, 6306–6312
23. Yu, K., Duran, C., Qu, Z., Cui, Y. Y., and Hartzell, H. C. (2012) Explaining
calcium-dependent gating of anoctamin-1 chloride channels requires a
revised topology. Circ. Res. 110, 990–999
24. Tien, J., Peters, C. J., Wong, X. M., Cheng, T., Jan, Y. N., Jan, L. Y., and
Yang, H. (2014) A comprehensive search for calcium binding sites critical
for TMEM16A calcium-activated chloride channel activity. Elife
10.7554/eLIFE.02772
Re-entrant Loop Regulates ANO1 Channel Activation
902 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 290•NUMBER 2•JANUARY 9, 2015
25. Yu, K., Zhu, J., Qu, Z., Cui, Y. Y., and Hartzell, H. C. (2014) Activation of
the Ano1 (TMEM16A) chloride channel by calcium is not mediated by
calmodulin. J. Gen. Physiol. 143, 253–267
26. Tian, Y., Kongsuphol, P., Hug,M., Ousingsawat, J.,Witzgall, R., Schreiber,
R., and Kunzelmann, K. (2011) Calmodulin-dependent activation of the
epithelial calcium-dependent chloride channel TMEM16A. FASEB J. 25,
1058–1068
27. Vocke, K., Dauner, K., Hahn, A., Ulbrich, A., Broecker, J., Keller, S., Frings,
S., and Möhrlen, F. (2013) Calmodulin-dependent activation and inacti-
vation of anoctamin calcium-gated chloride channels. J. Gen. Physiol. 142,
381–404
28. Terashima, H., Picollo, A., and Accardi, A. (2013) Purified TMEM16A is
sufficient to form Ca2-activated Cl- channels. Proc. Natl. Acad. Sci.
U.S.A. 110, 19354–19359
29. Bill, A., Rosethorne, E. M., Kent, T. C., Fawcett, L., Burchell, L., van
Diepen, M. T., Marelli, A., Batalov, S., Miraglia, L., Orth, A. P., Renaud,
N. A., Charlton, S. J., Gosling, M., Gaither, L. A., and Groot-Kormelink,
P. J. (2014) High throughput mutagenesis for identification of residues
regulating human prostacyclin (hIP) receptor expression and function.
PLoS One 9, e97973
30. Qiu, Z., Dubin, A. E., Mathur, J., Tu, B., Reddy, K., Miraglia, L. J., Rein-
hardt, J., Orth, A. P., and Patapoutian, A. (2014) SWELL1, a plasmamem-
brane protein, is an essential component of volume-regulated anion chan-
nel. Cell 157, 447–458
31. Paran, Y., Lavelin, I., Naffar-Abu-Amara, S., Winograd-Katz, S., Liron, Y.,
Geiger, B., and Kam, Z. (2006) Development and application of automatic
high resolution lightmicroscopy for cell-based screens.Methods Enzymol.
414, 228–247
32. Bill, A., Hall, M. L., Borawski, J., Hodgson, C., Jenkins, J., Piechon, P., Popa,
O., Rothwell, C., Tranter, P., Tria, S., Wagner, T., Whitehead, L., and
Gaither, L. A. (2014) Small molecule facilitated degradation of ANO1–a
new targeting approach for anticancer therapeutics. J. Biol. Chem. 289,
11029–11041
33. McPate, M., Bhalay, G., Beckett, M., Fairbrother, S., Gosling, M., Groot-
Kormelink, P. J., Lane, R., Kent, T., Van Diepen, M. T., Tranter, P., and
Verkuyl, J. M. (2014) The development of automated patch clamp assays
for canonical transient receptor potential channels TRPC3, -6, and -7.
Assay Drug Dev. Technol. 12, 282–292
34. Jayaraman, S., Haggie, P., Wachter, R. M., Remington, S. J., and Verkman,
A. S. (2000) Mechanism and cellular applications of a green fluorescent
protein-based halide sensor. J. Biol. Chem. 275, 6047–6050
35. De La Fuente, R., Namkung, W., Mills, A., and Verkman, A. S. (2008)
Small-molecule screen identifies inhibitors of a human intestinal calcium-
activated chloride channel.Mol. Pharmacol. 73, 758–768
36. Scudieri, P., Sondo, E., Caci, E., Ravazzolo, R., and Galietta, L. J. (2013)
TMEM16A-TMEM16B chimaeras to investigate the structure-function
relationship of calcium-activated chloride channels. Biochem. J. 452,
443–455
37. Fallah, G., Romer, T., Detro-Dassen, S., Braam, U., Markwardt, F., and
Schmalzing,G. (2011)TMEM16A(a) /anoctamin-1 shares a homodimeric
architecture with CLC chloride channels. Mol. Cell. Proteomics
10.1074/mcp.M110.004697
38. Sheridan, J. T., Worthington, E. N., Yu, K., Gabriel, S. E., Hartzell, H. C.,
and Tarran, R. (2011) Characterization of the oligomeric structure of the
Ca2-activated Cl channel Ano1/TMEM16A. J. Biol. Chem. 286,
1381–1388
39. Tien, J., Lee, H. Y., Minor, D. L., Jr., Jan, Y. N., and Jan, L. Y. (2013)
Identification of a dimerization domain in the TMEM16A calcium-acti-
vated chloride channel (CaCC). Proc. Natl. Acad. Sci. U.S.A. 110,
6352–6357
40. Xiao, Q., Yu, K., Perez-Cornejo, P., Cui, Y., Arreola, J., and Hartzell, H. C.
(2011) Voltage- and calcium-dependent gating of TMEM16A/Ano1 chlo-
ride channels are physically coupled by the first intracellular loop. Proc.
Natl. Acad. Sci. U.S.A. 108, 8891–8896
41. Suzuki, T., Suzuki, J., and Nagata, S. (2014) Functional swapping between
transmembrane protein TMEM16A and TMEM16F. J. Biol. Chem. 289,
7438-7447
42. Sondo, E., Scudieri, P., Tomati, V., Caci, E., Mazzone, A., Farrugia, G.,
Ravazzolo, R., and Galietta, L. J. (2014) Non-canonical translation start
sites in the TMEM16A chloride channel. Biochim. Biophys. Acta 1838,
89–97
43. Maass, K., Fischer, M. A., Seiler, M., Temmerman, K., Nickel, W., and
Seedorf,M. (2009) A signal comprising a basic cluster and an amphipathic
-helix interacts with lipids and is required for the transport of Ist2 to the
yeast cortical ER. J. Cell Sci. 122, 625–635
44. Fischer, M. A., Temmerman, K., Ercan, E., Nickel, W., and Seedorf, M.
(2009) Binding of plasma membrane lipids recruits the yeast integral
membrane protein Ist2 to the cortical ER. Traffic 10, 1084–1097
45. Ludewig, U., Pusch, M., and Jentsch, T. J. (1996) Two physically distinct
pores in the dimeric ClC-0 chloride channel. Nature 383, 340–343
46. Jentsch, T. J., Stein, V., Weinreich, F., and Zdebik, A. A. (2002) Molecular
structure and physiological function of chloride channels. Physiol. Rev. 82,
503–568
47. Charlesworth, G., Plagnol, V., Holmström, K. M., Bras, J., Sheerin, U. M.,
Preza, E., Rubio-Agusti, I., Ryten, M., Schneider, S. A., Stamelou, M., Tra-
bzuni, D., Abramov, A. Y., Bhatia, K. P., and Wood, N. W. (2012) Muta-
tions in ANO3 cause dominant craniometrical dystonia: ion channel im-
plicated in pathogenesis. Am. J. Hum. Genet. 91, 1041–1050
48. Sarkozy, A., Hicks, D., Hudson, J., Laval, S. H., Barresi, R., Hilton-Jones, D.,
Deschauer, M., Harris, E., Rufibach, L., Hwang, E., Bashir, R., Walter,
M. C., Krause, S., van den Bergh, P., Illa, I., Pénisson-Besnier, I., DeWaele,
L., Turnbull, D., Guglieri,M., Schrank, B., Schoser, B., Seeger, J., Schreiber,
H., Gläser, D., Eagle,M., Bailey, G.,Walters, R., Longman, C., Norwood, F.,
Winer, J., Muntoni, F., Hanna, M., Roberts, M., Bindoff, L. A., Brierley, C.,
Cooper, R. G., Cottrell, D. A., Davies, N. P., Gibson, A., Gorman, G. S.,
Hammans, S., Jackson, A. P., Khan, A., Lane, R., McConville, J.,
McEntagart,M., Al-Memar,A.,Nixon, J., Panicker, J., Parton,M., Petty, R.,
Price, C. J., Rakowicz,W., Ray, P., Schapira, A. H., Swingler, R., Turner, C.,
Wagner, K. R., Maddison, P., Shaw, P. J., Straub, V., Bushby, K., and Loch-
müller, H. (2013) ANO5 gene analysis in a large cohort of patients with
anoctaminopathy: confirmation of male prevalence and high occurrence
of the common exon 5 gene mutation. Hum. Mutat. 34, 1111–1118
49. Bolduc, V., Marlow, G., Boycott, K. M., Saleki, K., Inoue, H., Kroon, J.,
Itakura, M., Robitaille, Y., Parent, L., Baas, F., Mizuta, K., Kamata, N.,
Richard, I., Linssen,W.H.,Mahjneh, I., de Visser,M., Bashir, R., and Brais,
B. (2010) Recessive mutations in the putative calcium-activated chloride
channel Anoctamin 5 cause proximal LGMD2L and distal MMD3 mus-
cular dystrophies. Am. J. Hum. Genet. 86, 213–221
50. Vermeer, S., Hoischen, A., Meijer, R. P., Gilissen, C., Neveling, K., Wi-
eskamp, N., de Brouwer, A., Koenig, M., Anheim, M., Assoum, M.,
Drouot, N., Todorovic, S., Milic-Rasic, V., Lochmüller, H., Stevanin, G.,
Goizet, C., David, A., Durr, A., Brice, A., Kremer, B., van de Warrenburg,
B. P., Schijvenaars,M.M., Heister, A., Kwint,M., Arts, P., van derWijst, J.,
Veltman, J., Kamsteeg, E. J., Scheffer, H., and Knoers, N. (2010) Targeted
next-generation sequencing of a 12.5 Mb homozygous region reveals
ANO10 mutations in patients with autosomal-recessive cerebellar ataxia.
Am. J. Hum. Genet. 87, 813–819
51. Namkung, W., Yao, Z., Finkbeiner, W. E., and Verkman, A. S. (2011)
Small-molecule activators of TMEM16A, a calcium-activated chloride
channel, stimulate epithelial chloride secretion and intestinal contraction.
FASEB J. 25, 4048–4062
52. Kumar, S., Namkung,W., Verkman, A. S., and Sharma, P. K. (2012) Novel
5-substituted benzyloxy-2-arylbenzofuran-3-carboxylic acids as calcium
activated chloride channel inhibitors. Bioorg. Med. Chem. 20, 4237–4244
53. Namkung, W., Phuan, P. W., and Verkman, A. S. (2011) TMEM16A in-
hibitors reveal TMEM16A as a minor component of calcium-activated
chloride channel conductance in airway and intestinal epithelial cells.
J. Biol. Chem. 286, 2365–2374
54. Jung, J., Nam, J. H., Park, H.W., Oh, U., Yoon, J. H., and Lee, M. G. (2013)
Dynamic modulation of ANO1/TMEM16A HCO3() permeability by
Ca2/calmodulin. Proc. Natl. Acad. Sci. U.S.A. 110, 360–365
55. Arreola, J., Melvin, J. E., and Begenisich, T. (1996) Activation of calcium-
dependent chloride channels in rat parotid acinar cells. J. Gen. Physiol.
108, 35–47
56. Kuruma, A., and Hartzell, H. C. (2000) Bimodal control of a Ca2-acti-
vated Cl channel by different Ca2 signals. J. Gen. Physiol. 115, 59–80
Re-entrant Loop Regulates ANO1 Channel Activation
JANUARY 9, 2015•VOLUME 290•NUMBER 2 JOURNAL OF BIOLOGICAL CHEMISTRY 903
